Background/Aims: Ischemia/reperfusion injury (IRI) plays a crucial role in renal transplantation and can cause renal failure associated with pyroptosis, a pro-inflammatory-induced programmed cell death. Small endogenous non-coding RNAs have been shown to be involved in renal ischemia/reperfusion injury. This study was performed to investigate which miRNAs regulate pyroptosis in response to renal ischemia/reperfusion injury and determine the mechanism underlying this regulation. Methods: An in vivo rat model of renal IRI was established, and the serum and kidneys were harvested 24 h after reperfusion to assess renal function and histological changes. For the in vitro study, the cultured human renal proximal tubular cell line HK-2 was subjected to 24 h of hypoxia (5% CO 2 , 1% O 2 , and 94% N 2 ) followed by 12 h of reoxygenation (5% CO 2 , 21% O 2 , and 74% N 2 ). The mRNA expression levels were analyzed by real-time PCR, and the protein expression levels were analyzed using Western blot, immunofluorescence staining and enzyme-linked immunosorbent assay (ELISA). Bioinformatics analyses were applied to predict miR-155 targets, which were then confirmed by a luciferase reporter assay. Results: We found that the levels of pyroptosis-related proteins, including caspase-1, caspase-11, IL-1β and IL-18, were significantly increased after renal ischemia/reperfusion injury. Similarly, hypoxia-reoxygenation injury (HRI) also induced pyroptosis in HK2 cells. Furthermore, our study revealed that miR-155 expression was substantially increased in the renal tissues of IRI rats and in HRI HK2 cells. Up-regulation of miR-155 promoted HK2 cell pyroptosis in HRI; conversely, knockdown of miR-155 attenuated this process. To understand the signaling mechanisms underlying the pro-pyroptotic activity of miR-155, we found that exogenous expression of miR-155 up-regulated the expression of caspase-1 as well as the pro-inflammatory cytokines IL-1β and IL-18. Moreover, miR-155 directly repressed FoxO3a
MiR-155 is Involved in Renal Ischemia

Introduction
Renal ischemia followed by reperfusion (I/R) due to by circulatory shock of different etiologies or by anesthesia, surgery, or transplantation is a major cause of acute renal failure (ARF) [1] [2] [3] [4] [5] [6] [7] . I/R injury causes structural damage of renal tubules by directly inducing death of renal tubular cells, and these dying cells may release signals that trigger renal inflammatory responses [8] [9] [10] [11] [12] [13] [14] . The cross-talk of these complex pathways eventually initiates the development and progression of ARF.
MicroRNAs (miRNAs) are endogenous, small non-coding RNAs of approximately 19-22 nucleotides in length that anneal to nearly complementary sequences in the 3' untranslated regions (3'-UTRs) of target mRNAs to either facilitate their degradation or repress the translation process [15] . Numerous studies have shown that miRNAs are involved in a wide variety of biological processes, including cell proliferation, differentiation, metastasis, apoptosis and immune responses [16] [17] [18] [19] ; moreover, they also function as prognostic markers in the development and progression of ischemic renal diseases by targeting pertinent genes [20] [21] [22] [23] [24] [25] [26] .
Pyroptosis is a pro-inflammatory programmed cell death [27] that has the biochemical and morphological characteristics of necrosis and apoptosis, but unlike apoptosis or necrosis [28] , pyroptosis results in the release of cytokines that activate pro-inflammatory immune cell mediators [29] [30] [31] [32] . Caspase-1 is activated during pyroptosis by a large supramolecular complex known as the pyroptosome and subsequently processes the proforms of the inflammatory cytokines interleukin (IL)-1β and IL-18 into their active forms to trigger or aggravate inflammatory responses [33] [34] [35] . Therefore, pyroptosis may not only lead to cell death but also play an important role in the cascade of reactions that lead to damaged tissues. Several studies have indicated that pyroptosis contributes to infectious diseases, nervous system disorders, and atherosclerosis [36] [37] [38] . During the development and progression of IRI, renal cell death and inflammation may influence the severity and prognosis of IRI [39] [40] [41] . Thus, up-regulated levels of IL-1 family members such as IL-1β and IL-18 in kidney tissues and urine may serve as a prognostic factor for the progression of IRI [42, 43] . Nevertheless, whether pyroptosis is involved in renal tubular cell death upon IRI and how pyroptosis and inflammatory cytokines are related remain unknown. The underlying mechanism by which pyroptosis acts during the development of IRI requires clarification. Moreover, few studies have focused on the participation of miRNAs in pyroptosis in ischemic renal diseases.
The aim of this study was to elucidate the essential role of miRNAs in regulating ischemic renal diseases and the underlying mechanisms. In this study, we demonstrated that miR-155 promoted renal tubular cell pyroptosis by directly targeting Forkhead box O3 (FoxO3a), a crucial regulator of diverse cellular activities, such as cell cycle arrest, oxidative scavenging, cell proliferation, survival and death. A protein downstream of FoxO3a, apoptosis repressor with caspase recruitment domain (ARC), which antagonizes both the intrinsic and the extrinsic pathways of cell death, was subsequently inhibited. Based on our results, we verified that miR-155 plays a crucial role in the pathogenesis of renal tubular cell pyroptosis, suggesting that miR-155 may be a potential therapeutic target in the treatment of ischemic renal diseases. 
Materials and Methods
Animals
Renal I/R model
A rat model of renal IRI was established as previously described by Yokota et al. [44] . Briefly, rats were fasted overnight, anesthetized by an intraperitoneal injection of 3% pentobarbital sodium (0.1 ml/100 g body weight), and subjected to an abdominal incision. Their rectal temperatures were maintained at 37°C using a thermistor connected to a servo-controlled heating pad (model D1-L, Haake, Tokyo, Japan). The renal pedicles of the IRI group of rats were dissected and clamped with non-traumatic clamps for 45 min. The renal pedicles were then reperfused in situ for 24 h, after which six rats from each group at each time point were euthanized by decapitation, and their renal tissues were carefully dissected for subsequent experiments. Sham-operated control rats were subjected to an abdominal incision but did not undergo clamping of the renal pedicles. Blood samples were collected from individual rats at each time point after reperfusion to measure concentrations of serum creatinine and blood urea nitrogen (BUN) by an automatic biochemistry analyzer (Hitachi 7060).
Measurement of malondialdehyde (MDA) content and superoxide dismutase (SOD) activity
Oxidative stress in the kidneys and HK2 cells was assessed by measuring the MDA content and SOD activity. MDA is a terminal product of lipid peroxidation; its intracellular concentration was determined with commercial kits (Beyotime) that use the thiobarbituric acid method to form a red product with a maximum absorbance at 535 nm. The results are reported as μmol per milligram of extracted protein. The SOD activity in the kidneys was detected using a Total Superoxide Dismutase Assay Kit (Beyotime) and reported as U/ mg protein.
Histology
Renal tissue samples were fixed in 10% formalin for 24 h and embedded in paraffin. The sections were then stained with hematoxylin and eosin.
Cell culture and H/R treatment
The human renal proximal tubular cell line HK-2 was obtained from American Type Culture Collection (Manassas, VA, USA), plated in 100-mm culture dishes, and cultured in Dulbecco's modified Eagle's medium (ThermoFisher) supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 2 mM glutamine, 100 μg/ mL streptomycin, and 1 mM HEPES buffer. The cultures were incubated at 37°C in humidified air containing 5% CO 2 . The medium was replaced every other day. For the H/R group, cells were exposed to hypoxia (5% CO 2 , 1% O 2 , and 94% N 2 ) for 24 h followed by 12 h of reoxygenation (5% CO 2 , 21% O 2 , and 74% N 2 ). To determine the effect of miR-155, cells were transfected with either miR-155 mimic or inhibitor (SigmaAldrich, MO, USA) by using PureFection reagents (System Biosciences, CA, USA) for 12 h before the H/R treatment.
Cell viability assay
At the end of the indicated time, HK2 cells were treated with CCK8 (10 μl/well, Sigma, USA) for an additional 2 h, then we recorded the absorbance at 450 nm using a microplate absorbance reader (Tecan, Safire II, Switzerland).
Western Blot
Cells were lysed in ice-cold RIPA lysis buffer (Solarbio, Beijing, China) containing 0.1 mM PMSF and a protease inhibitor (Roche) for 30 min on ice. Samples were subjected to 12% SDS-PAGE and transferred to nitrocellulose membranes. Blots were probed using the primary antibodies anti-caspase 1 (Abcam, Cambridge, UK), anti-caspase 11 (Abcam), anti-FoxO3a (Abcam), anti-ARC (Abcam), anti-BNIP3 L (Abcam) and anti-GAPDH (Santa Cruz Biotechnology). After four washes with PBS-Tween 20, horseradish peroxidaseconjugated secondary antibodies were added. The signals were detected with Pierce ® ECL Western blotting substrate (Pierce, Rockford, IL, USA) according to the directions of the manufacturer and exposed on X-ray films (Kodak, Rochester, NY, USA). Quantitative real-time polymerase chain reaction Total RNA was extracted from rat kidneys with TRIzol reagent (Invitrogen, Shanghai, China) according to the manufacturer's instructions. Total RNA (1 μg) was transcribed into cDNA by Superscript II reverse transcriptase (Invitrogen) and random primer oligonucleotides (Invitrogen). Real-time PCR was performed with the 7900 HT Real-Time PCR System (Applied Biosystems) for 40 cycles with GAPDH and as an internal control. The following primers were used in the study (Table 1) .
To analyze the expression of miRNAs, we used gene-specific TaqMan miRNA assay probes (Applied Biosystems, Foster City, CA). Briefly, we reverse-transcribed 1 mg of total RNA to cDNA using AMV reverse transcription (Takara, Kyoto, Japan) and a stem-loop RT primer (Applied Biosystems). miRNA expression in cells and tissues was normalized to U6 snRNA. We performed real-time PCR using a TaqMan PCR kit on the 7900 HT Real-Time PCR System. We ran all reactions, including controls without template, in triplicate. We then determined the threshold cycles (CT) values using fixed-threshold settings after the initial cycling was completed.
ELISA
Blood serum was collected to measure the IL-1β and IL-18 concentrations using an ELISA kit according to the manufacturer's instructions (uscn-SEA064R and uscn-SEA563Ra, respectively).
Immunofluorescence staining
For immunofluorescence staining, cultured HK2 cells were fixed with 4% buffered paraformaldehyde in PBS. Blocking solution (1% BSA and 0.1% Triton-X in PBS) was used to penetrate and incubate fixed cells at room temperature for 2 h. Primary antibodies against FoxO3a, caspase-1 and ARC diluted in PBS were added to the fixed samples overnight at 4°C, after which the appropriate secondary antibodies (Abcam) were incubated with the cells for 1 h at room temperature. The nuclei were stained using 4', 6-diamidino-2-phenylindole (DAPI; Beyotime, Shanghai, China) for 20 min at room temperature. Immunofluorescence was examined under a fluorescence microscope (Nikon 80i, Otawara, Tochigi, Japan).
Luciferase assay FoxO3a 3'-UTRs containing conserved miR-155 binding sites as well as 3'-UTRs with mutated sites were synthesized by Sangon Biotech (Shanghai) Co., Ltd. (Shanghai, China) and amplified by PCR. The forward primer was 5'-AGAAGTGTATGAGTGAGAGGCA-3', and the reverse primer was 5'-CTGGCTCACTGACAAGCAGA-3'. The PCR fragment was subcloned into the XhoI and NotI sites downstream from the luciferase gene in the psi-CHECK2 vector (Promega Biotech Co., Ltd., Madison, WI, USA). The 3'-UTR luciferase vector (150 ng) was cotransfected into HK2 cells with either miR-155 mimic or inhibitor using Lipofectamine 3000 (ThermoFisher); 20 ng of Renilla luciferase reporters were used as an internal control. 
com/cpb
After 48 h, the cells were collected and lysed. A luciferase activity assay was performed using the DualLuciferase Reporter Assay System (Promega Biotech Co., Ltd.) according to the manufacturer's instructions.
Statistical Analysis
Continuous variables are presented as the mean ± S.E.M. Analysis of variance (ANOVA) and post hoc Bonferroni analysis was conducted for multiple comparisons by GraphPad Prism 5.0 (GraphPad Software, Inc., La Jolla, CA, USA). P-values < 0.05 indicated a statistically significant difference.
Results
IRI induces renal pyroptosis and inflammation
To investigate the effects of IRI on renal pyroptosis and inflammation, a rat model of renal IRI was used in which groups of rats were subjected to either sham surgery or ischemiareperfusion surgery. The concentrations of serum creatinine and blood urea nitrogen were significantly elevated in rats subjected to IRI (Fig. 1a and b) . The morphology of the kidneys from these rats was also histologically examined (Fig. 1c) . Reoxygenation following ischemia causes tissue oxidative stress, which is considered an important contributor to IRI. Following ischemia-reperfusion, MDA content (Fig. 1d ) was greatly increased, and SOD activity (Fig.  1e ) was greatly decreased in kidneys, indicating elevated levels of oxidative stress. These data indicated that IRI induced renal tubule injury and impaired renal function in rats. Western blot analysis and qPCR revealed that the protein and mRNA levels of caspase-1 and caspase-11 were markedly elevated after injury (Fig. 1f) , and similar changes in IL-1β and IL-18 expression were consistently observed (Fig. 1h) . These results suggest that IRI induces renal pyroptosis and inflammation.
HRI induces pyroptosis in HK2 cells
To investigate whether pyroptosis is induced in renal tubular cells, HK2 cells were subjected to H/R treatment. As shown in Fig. 2a , compared with that of control cells, cell proliferation was markedly inhibited after H/R treatment (p < 0.05). Consistently, in cultured HK2 cells, H/R treatment increased the MDA content (Fig. 2b , p < 0.05) but decreased SOD activity (Fig. 2c, p < 0.05 ). Immunofluorescence analysis (Fig. 2d ) of HK2 cells showed that caspase-1 expression was remarkably increased after H/R treatment. Consistent with these findings, the protein and mRNA levels of caspase-1, caspase-11, IL-1β and IL-18 were significantly increased in the H/R group ( Fig. 2e and f) . These results suggest that pyroptosis was similarly induced in renal tubular HK2 cells after simulating IRI (HRI).
miR-155 is up-regulated and FoxO3a is down-regulated after H/R treatment in HK2 cells
We further investigated the possible involvement of miRNAs in I/R renal tissues. We began by measuring the levels of several miRNAs reportedly associated with renal ischemic diseases, including miR-10, miR-21, miR-24, miR-30d, miR-125b, miR-155, miR-489 and miR-687, in both normal and IRI renal tissues. The results showed that miR-155 demonstrated the most pronounced deregulation after IRI (Fig. 3a) . We subsequently determined whether miR-155 was involved in HRI in HK2 cells. Over-expression of miR-155 was consistently observed in H/R-treated HK2 cells compared with the control group (Fig. 3b) . Moreover, we observed significant down-regulation of FoxO3a in IRI renal tissue and HRI HK2 cells as determined by Western blotting analysis, qPCR (Fig. 3c ) and immunofluorescence staining (Fig. 3d) .
miR-155 directly targets FoxO3a in HK2 cells during HRI
We next performed a series of functional studies to determine the link between miR-155 and FoxO3a. Computational analysis predicted a conserved binding site for miR-155 in the 3'-UTR of the foxo3a gene (Fig. 4a) . To verify that miR-155 directly targets FoxO3a, we prepared luciferase report constructs carrying the wild-type or mutant FoxO3a 3'-UTR ( However, miR-155 failed to affect the luciferase activity elicited by the construct containing the FoxO3a 3'-UTR with the mutant miR-155 binding site (Fig. 4c) . As shown in Fig. 4d-f , transfection of miR-155 into HK2 cells remarkably reduced the protein and mRNA levels of FoxO3a. Conversely, FoxO3a was significantly up-regulated when miR-155 inhibitor was transfected into HK2 cells subjected to H/R treatment, indicating that FoxO3a is a direct target of miR-155. Recently, miRNAs have emerged as important mediators of translational control and as regulators of a wide range of biological processes [17] [18] [19] [20] [21] . Over-expression of miRNAs is a common phenomenon that occurs in various diseases, and aberrantly expressed miRNAs often participate in the pathogenesis of specific diseases, including ischemic renal diseases. For example, miR-92a [50] may be involved the mechanisms of ischemic injury disease and angiogenesis. Lorenzen et al. [51] reported that miR-24 promotes renal ischemic injury by stimulating apoptosis in endothelial and tubular epithelial cells. MiR-155 was reported [52] found that miR-155 expression is significantly increased and correlated with the increased expression of TNF-α, IL-1β, CD105, and caspase-3 as well as with leukocyte infiltration in human muscle tissues after IRI. Furthermore, Pellegrini found that miR-155 expression is profoundly increased following ischemic or toxic injury to the kidneys. However, there is no direct evidence indicating the role of miR-155 in pyroptosis in the setting of renal IRI. In this study, we identified several miRNAs that are highly relevant to IRI and found that miR-155 expression was remarkably increased both in HK2 cells (a human renal tubular cell line) subjected to HRI and in renal tissues from IRI rats. FoxO3a is involved in the inhibition of cell death and the promotion of cellular growth in ischemic renal diseases [53] . Several miRNA databases, including TargetScan, miRDB and miRanda, show that FoxO3a is a potential target gene for miR-155.
In this study, we used both gain-and loss-of-function techniques to manipulate miR-155 expression and investigate its regulatory effects on FoxO3a in HK2 cells. A luciferase reporter gene assay as well as protein and mRNA expression assays validated that FoxO3a is a direct target of miR-155. More importantly, over-expression of miR-155 resulted in increased levels of caspase-1, IL-1β and IL-18, whereas knockdown of miR-155 attenuated the inflammatory cell death of HK2 cells, indicating that anti-miR-155 could be a strategy for the prevention of renal pyroptosis. Taken together, we determined that miR-155 may affect renal pyroptosis by targeting FoxO3a and its downstream protein ARC.
In conclusion, our results provide the first evidence that renal pyroptosis due to IRI is promoted by miR-155 via direct targeting of Foxo3a. These findings illustrated a previously unknown pathway comprising miR-155, FoxO3a, ARC and caspase-1 that regulates renal pyroptosis. However, it is undeniable that the effects of miR-155 on ARF may be mediated by a variety of mechanisms in addition to the FoxO3a/ ARC/caspase-1 pathway, and further investigation is required to uncover any other mechanisms involved. The salient findings from the present study indicate the essential role of miR-155 in IRI and greatly contribute to our understanding of the role of pyroptosis in ischemic renal diseases.
